Momentum Biotechnologies ("Momentum"), a contract research organization ("CRO") specializing in mass spectrometry-based drug ...

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the U.S. Food and Drug Administration (FDA) has cleared the QIAstat-Dx Gastrointestinal Panel 2 Mini B for clinical use, further ...

"We are ecstatic to have W-2 back on our home planet safely and are proud to support significant reentry research for our ...

Looking back on drug development inputs & services stocks’ Q4 earnings, we examine this quarter’s best and worst performers, ...

EDWARD ALDEN is a Senior Fellow at the Council on Foreign Relations and a former Washington Bureau Chief for the Financial ...

Pesticides and chemicals can stick to produce you bring home from the store. But some fruits and vegetables are more ...

On this special episode of “Uncanny Valley,” we talk about Elon Musk’s move to put spending limits on US government employee ...

Aldeyra's reproxalap faced an FDA setback but showed positive trial results, leading to a resubmitted NDA. Click here to find ...

Suvoda LLC, a global clinical trial technology company that specializes in complex studies in therapeutic areas like oncology, central nervous system (CNS), and rare disease, today announced the early ...

For pediatric insomnia, Dr Umakanth Katwa and Dr Rafael Pelayo call for a blend of clinical expertise, behavioral therapy, ...

Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to ...

For many seniors — including the more than 66 million Americans who are beneficiaries of Medicare, the federal health insurance program primarily for older adults — age-related cognitive decline ...